Publications
35
Citations
6,204
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1995
Mark E. Drew's research focuses on the biochemistry of parasites that cause diseases such as malaria and leishmaniasis, including work on Trypanosoma species. A specific focus has been studying enzymes like hexokinase (a protein involved in sugar metabolism) in Plasmodium (malaria-causing) parasites, including their structure and potential as drug targets. This work supports efforts to find new treatments for parasitic diseases.
Publication output has been very low and sporadic over the last decade, with only a few recorded outputs and no consistent yearly activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- <i>Plasmodium vivax</i>and human hexokinases share similar active sites but display distinct quaternary architectures
IUCrJ · 2020
- Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic Activity
Antimicrobial Agents and Chemotherapy · 2016
- Elsevier eBooks×2
- Journal of Cystic Fibrosis×1
- Antimicrobial Agents and Chemotherapy×1
- IUCrJ×1
- Valeria Garcia
Medicine · Purdue University West Lafayette
- April C. Joice
Medicine · The Ohio State University
- Rodolpho Ornitz Oliveira Souza
Medicine · Indiana University
- Bradford S. McGwire
Medicine · The Ohio State University
- Abhay R. Satoskar
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile